• Profile
Close

Safety and efficacy of exposure-based risk reduction through family therapy for co-occurring substance use problems and posttraumatic stress disorder symptoms among adolescents: A randomized clinical trial

JAMA Feb 14, 2020

Danielson CK, Adams Z, McCart MR, et al. - A randomized clinical trial was designed to ascertain whether an exposure-based, integrative intervention for adolescents with substance use problems (SUP) and posttraumatic stress disorder (PTSD) symptoms—risk reduction through family therapy (RRFT)—resulted in improved outcomes relative to a treatment-as-usual (TAU) control condition consisting primarily of trauma-focused cognitive behavioral therapy. This study included a total of 124 adolescents (mean [SD] age, 15.4 [1.3] years; 108 female [87.1%]) between November 1, 2012, and January 30, 2017. Individuals were assigned randomly to receive RRFT (n = 61) or TAU (n = 63). The outcomes of this study demonstrated that risk reduction through family therapy and TAU showed within-group improvements in SUP and PTSD symptoms, with the greater increase for substance use and PTSD avoidance and hyperarousal symptoms among adolescents randomized to RRFT compared with TAU.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay